PGP and cancer: These transporters, such as multidrug resistance protein 2 (MRP2), breast cancer resistance protein (BCRP), and P-glycoprotein (P-gp), are pivotal in mediating drug efflux from cancer cells, thus contributing to the development of chemotherapy resistance [1].